HYDROXOCOBALAMIN

HYDROXOCOBALAMIN was reported 4238 times

HYDROXOCOBALAMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY FLUID ANALYSIS 2 0.5000
1 SERUM COLOUR ABNORMAL 4 0.2000
2 NEUROPATHY VITAMIN B12 DEFICIENCY 9 0.1800
3 BLOOD CYANIDE INCREASED 3 0.1667
4 BLOOD COBALT INCREASED 2 0.1667
5 INTERNAL LIMITING MEMBRANE PEELING 2 0.1538
6 GENITAL HYPERAESTHESIA 2 0.1333
7 COLONIC ANGIOECTASIA 2 0.1250
8 FUNGURIA 4 0.1081
9 HEAVY METAL INCREASED 2 0.0909
10 DRUG-DEVICE INTERACTION 10 0.0901
11 ALEXITHYMIA 4 0.0800
12 FORCEPS DELIVERY 10 0.0769
13 GENITAL DISORDER 10 0.0746
14 MEAN ARTERIAL PRESSURE INCREASED 5 0.0714
15 CHEMICAL BURN OF ORAL CAVITY 3 0.0682
16 PELVIC DEFORMITY 7 0.0543
17 PULMONARY HILAR ENLARGEMENT 3 0.0536
18 CARBOXYHAEMOGLOBIN INCREASED 2 0.0333
19 PYROGLUTAMIC ACIDOSIS 12 0.0302
20 BILIRUBINURIA 3 0.0286
21 AIRWAY COMPLICATION OF ANAESTHESIA 7 0.0266
22 PARAPHILIA 3 0.0231
23 CHILLBLAINS 6 0.0230
24 HIP DYSPLASIA 5 0.0226
25 LOSS OF PROPRIOCEPTION 7 0.0217
26 PENILE ULCERATION 7 0.0214
27 LEUKAEMIA PLASMACYTIC 3 0.0185
28 OESOPHAGITIS HAEMORRHAGIC 5 0.0178
29 LABORATORY TEST INTERFERENCE 13 0.0165
30 VITAMIN B1 DEFICIENCY 7 0.0164
31 VITAMIN B12 ABNORMAL 3 0.0152
32 STATUS ASTHMATICUS 7 0.0148
33 BLOOD HOMOCYSTEINE INCREASED 6 0.0140
34 PRESBYACUSIS 4 0.0130
35 BILIARY SEPSIS 6 0.0130
36 SKIN TURGOR DECREASED 5 0.0129
37 PHOTODERMATOSIS 5 0.0118
38 HEMIPLEGIC MIGRAINE 4 0.0118
39 FOOD REFUSAL 10 0.0114
40 THYROXINE FREE DECREASED 6 0.0106
41 HAEMOFILTRATION 2 0.0105
42 OESOPHAGEAL ADENOCARCINOMA 5 0.0105
43 CRYSTAL NEPHROPATHY 6 0.0101
44 DEVICE INTERACTION 2 0.0084
45 CARDIAC FAILURE HIGH OUTPUT 2 0.0083
46 PERIODIC LIMB MOVEMENT DISORDER 3 0.0082
47 ALLERGIC COUGH 6 0.0078
48 POVERTY OF SPEECH 3 0.0077
49 MILK-ALKALI SYNDROME 4 0.0076
50 HYPERHOMOCYSTEINAEMIA 2 0.0076
51 GASTRIC ANTRAL VASCULAR ECTASIA 4 0.0076
52 TEMPORAL ARTERITIS 7 0.0076
53 DEVELOPMENTAL HIP DYSPLASIA 6 0.0072
54 CRYSTAL URINE PRESENT 4 0.0072
55 VASOPLEGIA SYNDROME 11 0.0067
56 LOCKED-IN SYNDROME 3 0.0065
57 METHAEMOGLOBINAEMIA 15 0.0065
58 NEUTROPENIC SEPSIS 45 0.0063
59 PANCREATITIS NECROTISING 14 0.0061
60 ULNA FRACTURE 6 0.0061
61 EXOSTOSIS OF JAW 3 0.0060
62 PLEURAL THICKENING 4 0.0058
63 URGE INCONTINENCE 5 0.0057
64 PERIPHERAL SENSORIMOTOR NEUROPATHY 7 0.0056
65 HALO VISION 6 0.0053
66 DIFFUSE ALVEOLAR DAMAGE 6 0.0052
67 BLOOD URINE 5 0.0052
68 COMA SCALE ABNORMAL 15 0.0052
69 MACROCEPHALY 2 0.0052
70 HYPORESPONSIVE TO STIMULI 6 0.0051
71 FALSE POSITIVE INVESTIGATION RESULT 5 0.0050
72 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 4 0.0049
73 HAEMORRHAGE IN PREGNANCY 7 0.0049
74 ANTEPARTUM HAEMORRHAGE 2 0.0048
75 CARDITIS 2 0.0048
76 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
77 VASCULAR DEMENTIA 4 0.0046
78 BLOOD MAGNESIUM INCREASED 4 0.0044
79 SARCOMA 5 0.0044
80 GASTROINTESTINAL STOMA OUTPUT INCREASED 2 0.0043
81 ACUTE LUNG INJURY 5 0.0042
82 PLEURAL FIBROSIS 4 0.0039
83 RENAL MASS 8 0.0039
84 MUSCLE DISCOMFORT 3 0.0038
85 VITAMIN B12 INCREASED 3 0.0038
86 ALVEOLITIS 5 0.0035
87 HEAD BANGING 2 0.0035
88 NONINFECTIVE GINGIVITIS 5 0.0035
89 NYSTAGMUS 18 0.0034
90 SKIN ABRASION 16 0.0034
91 DERMO-HYPODERMITIS 2 0.0034
92 GINGIVAL HYPERTROPHY 5 0.0033
93 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 2 0.0033
94 HYPOMANIA 12 0.0033
95 ACUTE PSYCHOSIS 8 0.0032
96 BILIARY TRACT INFECTION 2 0.0032
97 VITAMIN B12 DEFICIENCY 13 0.0032
98 MONOCLONAL GAMMOPATHY 2 0.0032
99 INHIBITORY DRUG INTERACTION 5 0.0032
100 CONVERSION DISORDER 6 0.0031
101 DUODENAL PERFORATION 3 0.0031
102 INFUSION SITE URTICARIA 2 0.0030
103 IMMUNE-MEDIATED DERMATITIS 3 0.0030
104 CHROMATURIA 67 0.0030
105 TONGUE DRY 4 0.0029
106 ACIDOSIS 22 0.0029
107 ORTHOSTATIC HYPOTENSION 50 0.0029
108 INFUSION SITE INFLAMMATION 2 0.0028
109 PENIS DISORDER 7 0.0028
110 NONINFECTIVE ENCEPHALITIS 2 0.0028
111 CANCER PAIN 7 0.0027
112 NORMOCYTIC ANAEMIA 4 0.0027
113 PNEUMONIA ASPIRATION 68 0.0027
114 INFECTED SKIN ULCER 5 0.0026
115 ORAL MUCOSAL ERUPTION 4 0.0026
116 SCLERITIS 4 0.0025
117 SKIN HYPERTROPHY 7 0.0025
118 MUCOSAL DRYNESS 5 0.0025
119 GLOMERULONEPHRITIS 6 0.0024
120 HYPONATRAEMIA 138 0.0024
121 PSYCHOTIC SYMPTOM 5 0.0024
122 BLOOD PRESSURE DIASTOLIC ABNORMAL 6 0.0024
123 SPLENIC INFARCTION 4 0.0023
124 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
125 CATARRH 2 0.0022
126 LIP BLISTER 6 0.0022
127 APPLICATION SITE INFLAMMATION 3 0.0022
128 URINARY HESITATION 5 0.0021
129 POST HERPETIC NEURALGIA 3 0.0021
130 IDIOPATHIC PULMONARY FIBROSIS 8 0.0020
131 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
132 CREPITATIONS 6 0.0020
133 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
134 AORTIC STENOSIS 7 0.0020
135 HYPOAESTHESIA FACIAL 3 0.0020
136 DILATED CARDIOMYOPATHY 2 0.0020
137 AUTONOMIC NEUROPATHY 2 0.0020
138 BREAST ABSCESS 2 0.0020
139 STOMA SITE HAEMORRHAGE 3 0.0019
140 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
141 COGWHEEL RIGIDITY 2 0.0019
142 INTESTINAL ULCER 3 0.0019
143 HYPERKINESIA 4 0.0019
144 ATRIAL FLUTTER 15 0.0019
145 JC VIRUS INFECTION 3 0.0019
146 IDIOPATHIC URTICARIA 2 0.0019
147 INFUSION SITE MASS 2 0.0018
148 LIVER FUNCTION TEST ABNORMAL 53 0.0018
149 LIP SWELLING 60 0.0018
150 HEART RATE ABNORMAL 10 0.0018
151 DISTRIBUTIVE SHOCK 4 0.0018
152 ABNORMAL LOSS OF WEIGHT 12 0.0018
153 BLOOD AMYLASE INCREASED 3 0.0018
154 UROSEPSIS 16 0.0017
155 FOLATE DEFICIENCY 2 0.0017
156 FLAT AFFECT 4 0.0017
157 HYPOMAGNESAEMIA 24 0.0017
158 BLOOD LACTIC ACID INCREASED 9 0.0017
159 DEVICE ALARM ISSUE 3 0.0017
160 CLOSTRIDIUM COLITIS 2 0.0016
161 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
162 DYSCHEZIA 5 0.0016
163 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
164 BRAIN DEATH 5 0.0016
165 ABDOMINAL TENDERNESS 8 0.0016
166 MYELOPATHY 3 0.0016
167 NOCTURNAL DYSPNOEA 2 0.0016
168 COMMUNICATION DISORDER 6 0.0016
169 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
170 URINE OUTPUT INCREASED 4 0.0015
171 MALABSORPTION 8 0.0015
172 PSYCHOMOTOR SKILLS IMPAIRED 4 0.0015
173 OESOPHAGEAL HAEMORRHAGE 2 0.0015
174 ANXIETY DISORDER 5 0.0015
175 CYSTITIS NONINFECTIVE 2 0.0015
176 HUMERUS FRACTURE 7 0.0015
177 PHARYNGEAL ERYTHEMA 3 0.0014
178 FANCONI SYNDROME 2 0.0014
179 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
180 SWOLLEN TONGUE 44 0.0014
181 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
182 EXERCISE TOLERANCE DECREASED 8 0.0014
183 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
184 EXPOSED BONE IN JAW 3 0.0014
185 DERMATITIS BULLOUS 10 0.0014
186 ACUTE KIDNEY INJURY 211 0.0014
187 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
188 CEREBELLAR SYNDROME 3 0.0014
189 DYSPHEMIA 6 0.0014
190 HYPOVOLAEMIA 8 0.0014
191 STRABISMUS 4 0.0014
192 FAECES PALE 3 0.0013
193 BRAIN HERNIATION 4 0.0013
194 PARTIAL SEIZURES 7 0.0013
195 CHEILITIS 7 0.0013
196 GASTROSTOMY 2 0.0013
197 METABOLIC ACIDOSIS 41 0.0013
198 BLEPHAROSPASM 8 0.0013
199 STREPTOCOCCAL INFECTION 7 0.0013
200 HYPOVOLAEMIC SHOCK 6 0.0013
201 TRIGEMINAL NEURALGIA 5 0.0012
202 RASH VESICULAR 6 0.0012
203 CARDIAC FLUTTER 8 0.0012
204 PARKINSONISM 12 0.0012
205 OEDEMA MOUTH 4 0.0012
206 OXYGEN THERAPY 2 0.0012
207 DEAFNESS NEUROSENSORY 4 0.0012
208 ILEUS 15 0.0012
209 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
210 COMA 57 0.0012
211 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
212 PETIT MAL EPILEPSY 6 0.0012
213 FEMORAL NECK FRACTURE 6 0.0012
214 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
215 SWELLING FACE 72 0.0011
216 SUBDURAL HAEMORRHAGE 3 0.0011
217 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
218 GASTRIC ULCER HAEMORRHAGE 6 0.0011
219 ERYTHEMA MULTIFORME 10 0.0011
220 HYPERKALAEMIA 37 0.0011
221 MOUTH ULCERATION 22 0.0010
222 VITAMIN B12 DECREASED 3 0.0010
223 DYSPNOEA AT REST 3 0.0010
224 RASH MACULO-PAPULAR 23 0.0010
225 APHTHOUS ULCER 8 0.0010
226 HAEMATEMESIS 26 0.0010
227 EPIGASTRIC DISCOMFORT 4 0.0010
228 BRADYCARDIA 54 0.0010
229 BRADYKINESIA 6 0.0010
230 INFLAMMATORY MARKER INCREASED 5 0.0010
231 CEREBRAL ATROPHY 4 0.0010
232 INTRACRANIAL ANEURYSM 4 0.0010
233 CEREBROVASCULAR DISORDER 3 0.0010
234 SENSORY LOSS 8 0.0010
235 DEVICE RELATED SEPSIS 2 0.0010
236 ORGAN FAILURE 4 0.0010
237 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
238 LIVER INJURY 24 0.0010
239 ANAPHYLACTOID REACTION 4 0.0010
240 PARAESTHESIA ORAL 14 0.0010
241 PANIC REACTION 7 0.0010
242 CAPILLARY LEAK SYNDROME 2 0.0010
243 SPINAL COMPRESSION FRACTURE 8 0.0010
244 SKIN NECROSIS 5 0.0010
245 COAGULOPATHY 16 0.0010
246 MELAENA 21 0.0010
247 DEVICE MATERIAL ISSUE 2 0.0010
248 HYPOCALCAEMIA 18 0.0010
249 HALLUCINATIONS, MIXED 4 0.0010
250 INFUSION SITE PRURITUS 3 0.0009
251 BUNDLE BRANCH BLOCK LEFT 4 0.0009
252 LIPODYSTROPHY ACQUIRED 2 0.0009
253 HYPOPHAGIA 24 0.0009
254 ANAEMIA MACROCYTIC 2 0.0009
255 PEMPHIGOID 7 0.0009
256 URINE OUTPUT DECREASED 8 0.0009
257 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
258 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
259 GASTROINTESTINAL ULCER 2 0.0009
260 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
261 FACIAL PAIN 8 0.0009
262 LETHARGY 51 0.0009
263 DIPLOPIA 23 0.0009
264 CIRCULATORY COLLAPSE 15 0.0009
265 HAEMATOCRIT INCREASED 2 0.0009
266 FAECES DISCOLOURED 19 0.0009
267 RESPIRATION ABNORMAL 6 0.0009
268 PARANOIA 15 0.0009
269 DEPRESSION SUICIDAL 3 0.0009
270 HICCUPS 7 0.0009
271 COLITIS MICROSCOPIC 4 0.0008
272 ATAXIA 10 0.0008
273 SKIN WEEPING 3 0.0008
274 SUBDURAL HAEMATOMA 12 0.0008
275 HALLUCINATION 63 0.0008
276 DELIRIUM 29 0.0008
277 DIZZINESS POSTURAL 8 0.0008
278 CUTANEOUS VASCULITIS 3 0.0008
279 DEVICE INFUSION ISSUE 2 0.0008
280 CHOLANGITIS 5 0.0008
281 AKATHISIA 11 0.0008
282 HALLUCINATION, VISUAL 17 0.0008
283 INJECTION SITE ABSCESS 2 0.0008
284 PERIPHERAL COLDNESS 11 0.0008
285 CONFUSIONAL STATE 129 0.0008
286 AUTOIMMUNE THYROIDITIS 3 0.0008
287 PHOTOPSIA 5 0.0008
288 APPENDICITIS PERFORATED 2 0.0008
289 ANGLE CLOSURE GLAUCOMA 2 0.0008
290 BOWEL MOVEMENT IRREGULARITY 6 0.0008
291 C-REACTIVE PROTEIN INCREASED 28 0.0008
292 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
293 HAND DEFORMITY 10 0.0008
294 AGEUSIA 19 0.0008
295 WHEEZING 45 0.0008
296 IRON DEFICIENCY ANAEMIA 7 0.0008
297 HYPERLACTACIDAEMIA 2 0.0007
298 DYSARTHRIA 28 0.0007
299 JAUNDICE 20 0.0007
300 BRADYPNOEA 2 0.0007
301 LACTIC ACIDOSIS 24 0.0007
302 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
303 GAMBLING DISORDER 2 0.0007
304 GINGIVAL BLEEDING 10 0.0007
305 ACUTE CORONARY SYNDROME 6 0.0007
306 ELECTROCARDIOGRAM QT PROLONGED 26 0.0007
307 ON AND OFF PHENOMENON 4 0.0007
308 CONGESTIVE CARDIOMYOPATHY 3 0.0007
309 SELF-INJURIOUS IDEATION 3 0.0007
310 ANGIOPATHY 4 0.0007
311 SLEEP TERROR 3 0.0007
312 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
313 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
314 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
315 DUODENAL ULCER HAEMORRHAGE 2 0.0007
316 SHOCK 16 0.0007
317 GASTROOESOPHAGEAL REFLUX DISEASE 56 0.0007
318 HEPATIC LESION 3 0.0007
319 MOUTH SWELLING 4 0.0007
320 BLOOD URIC ACID INCREASED 4 0.0007
321 ELECTROLYTE IMBALANCE 8 0.0007
322 NEGATIVE THOUGHTS 2 0.0007
323 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
324 IMMUNOSUPPRESSION 6 0.0007
325 BLOOD CREATINE INCREASED 3 0.0007
326 HYPOPHOSPHATAEMIA 5 0.0007
327 PLEURISY 4 0.0007
328 PANCREATITIS ACUTE 15 0.0007
329 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
330 PAPILLOEDEMA 3 0.0007
331 RENAL PAIN 7 0.0007
332 DIABETIC FOOT 2 0.0007
333 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
334 YELLOW SKIN 3 0.0006
335 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
336 ASPIRATION 7 0.0006
337 SPINAL COLUMN STENOSIS 3 0.0006
338 BLOOD ALBUMIN DECREASED 5 0.0006
339 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
340 HYPOXIA 22 0.0006
341 BLOOD DISORDER 5 0.0006
342 EYE SWELLING 23 0.0006
343 HAEMORRHOIDS 12 0.0006
344 GOUT 11 0.0006
345 HYPERVOLAEMIA 3 0.0006
346 PELVIC PAIN 11 0.0006
347 OTITIS MEDIA 2 0.0006
348 ORGANISING PNEUMONIA 3 0.0006
349 RECTAL HAEMORRHAGE 26 0.0006
350 FLUID INTAKE REDUCED 3 0.0006
351 TERMINAL STATE 4 0.0006
352 ERYSIPELAS 3 0.0006
353 TOE AMPUTATION 3 0.0006
354 HEPATIC CYST 2 0.0006
355 PSEUDOMONAS INFECTION 5 0.0006
356 HYPOPNOEA 2 0.0006
357 PULMONARY FIBROSIS 11 0.0006
358 NECROTISING FASCIITIS 2 0.0006
359 SOMNOLENCE 114 0.0006
360 JAUNDICE CHOLESTATIC 2 0.0006
361 LYMPHOPENIA 8 0.0006
362 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
363 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
364 HAEMORRHAGIC DIATHESIS 2 0.0006
365 SENSORY DISTURBANCE 9 0.0006
366 DERMATITIS ALLERGIC 7 0.0006
367 CELLULITIS 28 0.0006
368 FOOD INTOLERANCE 2 0.0005
369 RASH MACULAR 19 0.0005
370 DYSURIA 20 0.0005
371 ANGIOEDEMA 24 0.0005
372 AGGRESSION 27 0.0005
373 ORAL PAIN 12 0.0005
374 SQUAMOUS CELL CARCINOMA 5 0.0005
375 PERONEAL NERVE PALSY 3 0.0005
376 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
377 MEDICATION ERROR 29 0.0005
378 PHARYNGEAL OEDEMA 8 0.0005
379 HAEMOLYSIS 4 0.0005
380 DYSKINESIA 21 0.0005
381 METABOLIC DISORDER 3 0.0005
382 PHARYNGEAL SWELLING 5 0.0005
383 DEHYDRATION 68 0.0005
384 ACUTE MYOCARDIAL INFARCTION 15 0.0005
385 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
386 OESOPHAGEAL PAIN 2 0.0005
387 MENTAL STATUS CHANGES 14 0.0005
388 UNRESPONSIVE TO STIMULI 13 0.0005
389 TRICUSPID VALVE INCOMPETENCE 4 0.0005
390 CEREBRAL HAEMORRHAGE 18 0.0005
391 MUSCLE RIGIDITY 6 0.0005
392 WOUND 14 0.0005
393 CARPAL TUNNEL SYNDROME 7 0.0005
394 BRAIN INJURY 5 0.0005
395 TOOTHACHE 9 0.0005
396 HYPOGLYCAEMIA 24 0.0005
397 INGUINAL HERNIA 3 0.0005
398 TENSION 3 0.0005
399 DRY THROAT 5 0.0005
400 RESTLESSNESS 18 0.0005
401 GASTROINTESTINAL DISORDER 44 0.0005
402 HELICOBACTER INFECTION 5 0.0005
403 ARRHYTHMIA 23 0.0005
404 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
405 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
406 SWELLING OF EYELID 3 0.0005
407 ONYCHOMADESIS 2 0.0005
408 BRAIN OEDEMA 6 0.0005
409 INTESTINAL STENOSIS 2 0.0005
410 PERIPHERAL SWELLING 73 0.0005
411 JOINT DISLOCATION 5 0.0005
412 ANAPHYLACTIC REACTION 26 0.0005
413 CARDIAC FAILURE CHRONIC 2 0.0005
414 INTERVERTEBRAL DISC DISORDER 2 0.0005
415 HAEMORRHAGE INTRACRANIAL 7 0.0005
416 GLAUCOMA 9 0.0005
417 SKIN ULCER 12 0.0005
418 APPLICATION SITE VESICLES 3 0.0005
419 PRURITUS GENERALISED 10 0.0005
420 PYELONEPHRITIS 4 0.0005
421 PALPITATIONS 54 0.0005
422 DIABETIC KETOACIDOSIS 11 0.0005
423 BEDRIDDEN 6 0.0005
424 GASTRITIS 12 0.0005
425 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
426 TENDONITIS 7 0.0005
427 MENINGITIS 3 0.0004
428 BASAL CELL CARCINOMA 7 0.0004
429 MALNUTRITION 5 0.0004
430 IRON DEFICIENCY 2 0.0004
431 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
432 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
433 PNEUMONITIS 12 0.0004
434 CHEST DISCOMFORT 45 0.0004
435 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
436 CROHN'S DISEASE 3 0.0004
437 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
438 APPLICATION SITE RASH 6 0.0004
439 CARDIAC ARREST 36 0.0004
440 DEPRESSED MOOD 23 0.0004
441 DROOLING 3 0.0004
442 MUSCLE TWITCHING 10 0.0004
443 ENCEPHALITIS 3 0.0004
444 HAIR GROWTH ABNORMAL 3 0.0004
445 LARGE INTESTINE POLYP 3 0.0004
446 DUODENAL ULCER 3 0.0004
447 BLOOD PROLACTIN INCREASED 2 0.0004
448 GESTATIONAL DIABETES 2 0.0004
449 DRY MOUTH 34 0.0004
450 INCREASED APPETITE 8 0.0004
451 MYALGIA 71 0.0004
452 GASTROINTESTINAL TOXICITY 2 0.0004
453 DRUG-INDUCED LIVER INJURY 13 0.0004
454 GUILLAIN-BARRE SYNDROME 2 0.0004
455 HYPOKALAEMIA 19 0.0004
456 GASTROENTERITIS 6 0.0004
457 UNDERDOSE 30 0.0004
458 RENAL TUBULAR NECROSIS 4 0.0004
459 MUSCULOSKELETAL DISCOMFORT 7 0.0004
460 SMALL INTESTINAL OBSTRUCTION 5 0.0004
461 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
462 JOINT SWELLING 49 0.0004
463 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
464 CEREBRAL DISORDER 3 0.0004
465 DRUG WITHDRAWAL SYNDROME NEONATAL 6 0.0004
466 URINARY INCONTINENCE 12 0.0004
467 PALLOR 11 0.0004
468 MOOD ALTERED 11 0.0004
469 CYST 5 0.0004
470 NEUROTOXICITY 7 0.0004
471 TOXIC SKIN ERUPTION 4 0.0004
472 COLITIS 15 0.0004
473 OSTEOPENIA 6 0.0004
474 HYPOTHERMIA 4 0.0004
475 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
476 SEPSIS 44 0.0004
477 TROPONIN INCREASED 3 0.0004
478 PARAESTHESIA 62 0.0004
479 BALANCE DISORDER 34 0.0004
480 SUBARACHNOID HAEMORRHAGE 4 0.0004
481 SYNCOPE 39 0.0004
482 HAEMOGLOBIN DECREASED 40 0.0004
483 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
484 ATRIOVENTRICULAR BLOCK 3 0.0004
485 ANAPHYLACTIC SHOCK 10 0.0004
486 EJECTION FRACTION DECREASED 6 0.0004
487 OEDEMA PERIPHERAL 47 0.0004
488 RESTLESS LEGS SYNDROME 7 0.0004
489 ANGER 13 0.0004
490 HYPOTENSION 77 0.0004
491 PETECHIAE 4 0.0004
492 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
493 MULTIPLE ALLERGIES 3 0.0004
494 ABDOMINAL PAIN 89 0.0004
495 MUCOSAL INFLAMMATION 10 0.0004
496 LEUKOPENIA 19 0.0004
497 GINGIVAL PAIN 3 0.0004
498 RASH ERYTHEMATOUS 18 0.0004
499 PSYCHOTIC DISORDER 11 0.0004
500 SKIN CANCER 8 0.0004
501 PRESYNCOPE 9 0.0004
502 BEHAVIOUR DISORDER 2 0.0004
503 BLOOD POTASSIUM INCREASED 6 0.0004
504 MENSTRUATION DELAYED 4 0.0004
505 RASH PRURITIC 20 0.0004
506 RENAL IMPAIRMENT 31 0.0004
507 POST PROCEDURAL INFECTION 3 0.0004
508 DECUBITUS ULCER 3 0.0004
509 ABNORMAL FAECES 3 0.0004
510 MUSCLE SPASMS 67 0.0004
511 BLOOD GLUCOSE FLUCTUATION 4 0.0004
512 SKIN LESION 10 0.0004
513 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
514 AUTISM SPECTRUM DISORDER 2 0.0004
515 NEUTROPENIA 49 0.0004
516 HAEMOPTYSIS 10 0.0004
517 NECK PAIN 20 0.0004
518 DIZZINESS 178 0.0004
519 HYPERGLYCAEMIA 13 0.0004
520 LIMB DISCOMFORT 11 0.0004
521 TREMOR 59 0.0004
522 VOMITING 167 0.0004
523 SKIN REACTION 5 0.0004
524 HEMIPARESIS 6 0.0004
525 RENAL FAILURE ACUTE 15 0.0004
526 ABNORMAL BEHAVIOUR 14 0.0004
527 CHOLECYSTITIS ACUTE 2 0.0004
528 DERMATITIS CONTACT 4 0.0004
529 HAEMATURIA 12 0.0004
530 OEDEMA 19 0.0003
531 HYPERSENSITIVITY 65 0.0003
532 HYPERTONIA 2 0.0003
533 BLOOD MAGNESIUM DECREASED 3 0.0003
534 MYOPATHY 3 0.0003
535 NIGHTMARE 12 0.0003
536 ENTEROCOLITIS 2 0.0003
537 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
538 METASTASES TO LUNG 4 0.0003
539 ANOSMIA 5 0.0003
540 DYSPNOEA EXERTIONAL 13 0.0003
541 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
542 TASTE DISORDER 7 0.0003
543 MALAISE 151 0.0003
544 SEDATION 9 0.0003
545 INTENTIONAL OVERDOSE 22 0.0003
546 CONTUSION 33 0.0003
547 COGNITIVE DISORDER 16 0.0003
548 OSTEOPOROSIS 14 0.0003
549 PANCYTOPENIA 19 0.0003
550 RESPIRATORY RATE INCREASED 3 0.0003
551 SEIZURE 39 0.0003
552 THIRST 6 0.0003
553 DYSPNOEA 190 0.0003
554 HYPERLIPIDAEMIA 4 0.0003
555 MYOSITIS 3 0.0003
556 EPISTAXIS 25 0.0003
557 DERMATITIS 7 0.0003
558 ANAL INCONTINENCE 3 0.0003
559 BLOOD BILIRUBIN INCREASED 9 0.0003
560 HYPOAESTHESIA ORAL 5 0.0003
561 APHASIA 10 0.0003
562 OSTEOARTHRITIS 14 0.0003
563 NEURALGIA 8 0.0003
564 FOETAL GROWTH RESTRICTION 2 0.0003
565 DISORIENTATION 13 0.0003
566 HYPOAESTHESIA 49 0.0003
567 ANAEMIA 62 0.0003
568 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
569 GENERALISED OEDEMA 4 0.0003
570 FEMUR FRACTURE 10 0.0003
571 DIARRHOEA HAEMORRHAGIC 3 0.0003
572 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
573 VISION BLURRED 44 0.0003
574 BLINDNESS 13 0.0003
575 INFUSION SITE SWELLING 2 0.0003
576 PAIN IN JAW 9 0.0003
577 DIARRHOEA 205 0.0003
578 SPINAL DISORDER 3 0.0003
579 PROTEINURIA 6 0.0003
580 TOXICITY TO VARIOUS AGENTS 53 0.0003
581 ULCER 5 0.0003
582 ANGINA PECTORIS 9 0.0003
583 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
584 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
585 PULMONARY OEDEMA 14 0.0003
586 DRUG INTOLERANCE 30 0.0003
587 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
588 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
589 KIDNEY INFECTION 6 0.0003
590 MENORRHAGIA 6 0.0003
591 HEPATOMEGALY 3 0.0003
592 THERAPY CHANGE 3 0.0003
593 TINNITUS 14 0.0003
594 MANIA 5 0.0003
595 PULMONARY CONGESTION 4 0.0003
596 VENTRICULAR TACHYCARDIA 5 0.0003
597 PANCREATITIS 16 0.0003
598 ERYTHEMA 62 0.0003
599 CARDIAC FAILURE ACUTE 2 0.0003
600 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
601 BRONCHIECTASIS 2 0.0003
602 PRURITUS 114 0.0003
603 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
604 NEUTROPHIL COUNT DECREASED 12 0.0003
605 NEUTROPHIL COUNT INCREASED 3 0.0003
606 INFARCTION 2 0.0003
607 MUSCULAR WEAKNESS 33 0.0003
608 LOCALISED INFECTION 7 0.0003
609 DECREASED APPETITE 67 0.0003
610 PRODUCT ODOUR ABNORMAL 3 0.0003
611 ENCEPHALOPATHY 7 0.0003
612 BLISTER 16 0.0003
613 COLD SWEAT 5 0.0003
614 SUDDEN DEATH 3 0.0003
615 PYREXIA 98 0.0003
616 LYMPHOCYTE COUNT DECREASED 5 0.0003
617 HAND FRACTURE 2 0.0003
618 DIALYSIS 4 0.0003
619 BODY HEIGHT DECREASED 3 0.0003
620 BREAST CANCER METASTATIC 3 0.0003
621 CARDIOGENIC SHOCK 4 0.0003
622 DRUG INTERACTION 44 0.0003
623 GASTROENTERITIS VIRAL 5 0.0003
624 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
625 FALL 92 0.0003
626 OSTEOMYELITIS 5 0.0003
627 PRODUCT PRESCRIBING ISSUE 6 0.0003
628 RASH 120 0.0003
629 FLUID OVERLOAD 4 0.0003
630 URTICARIA 46 0.0003
631 CARDIAC FAILURE 22 0.0003
632 HEPATITIS 7 0.0003
633 ORAL DISORDER 2 0.0003
634 DUODENAL ULCER PERFORATION 2 0.0003
635 SKIN INFECTION 3 0.0003
636 TYPE 2 DIABETES MELLITUS 9 0.0003
637 OCULAR DISCOMFORT 3 0.0003
638 PHOTOPHOBIA 5 0.0003
639 PLEURAL EFFUSION 16 0.0003
640 NEUROPATHY PERIPHERAL 25 0.0003
641 PNEUMONIA 85 0.0003
642 MYOCARDITIS 3 0.0003
643 NAUSEA 207 0.0003
644 LOWER LIMB FRACTURE 5 0.0003
645 ACUTE RESPIRATORY FAILURE 5 0.0003
646 AGITATION 19 0.0003
647 ERUCTATION 5 0.0003
648 DYSTONIA 5 0.0003
649 ATRIAL FIBRILLATION 25 0.0003
650 ACUTE MYELOID LEUKAEMIA 4 0.0003
651 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
652 SPINAL PAIN 3 0.0003
653 DRUG SCREEN POSITIVE 2 0.0003
654 PNEUMOTHORAX 4 0.0003
655 MYOCLONUS 3 0.0003
656 HYPOTHYROIDISM 8 0.0003
657 PREGNANCY 5 0.0002
658 EYE PAIN 14 0.0002
659 INTERSTITIAL LUNG DISEASE 12 0.0002
660 CONSTIPATION 54 0.0002
661 MENTAL IMPAIRMENT 6 0.0002
662 NOCTURIA 3 0.0002
663 PANIC ATTACK 9 0.0002
664 BONE MARROW FAILURE 5 0.0002
665 FLUSHING 25 0.0002
666 BLOOD CREATININE INCREASED 16 0.0002
667 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
668 ESCHERICHIA INFECTION 2 0.0002
669 OSTEONECROSIS OF JAW 6 0.0002
670 PHOTOSENSITIVITY REACTION 4 0.0002
671 MENSTRUAL DISORDER 2 0.0002
672 EOSINOPHIL COUNT INCREASED 2 0.0002
673 SKIN DISCOLOURATION 11 0.0002
674 INFUSION SITE ERYTHEMA 2 0.0002
675 MOBILITY DECREASED 17 0.0002
676 ABDOMINAL PAIN UPPER 48 0.0002
677 INFUSION SITE PAIN 3 0.0002
678 BACK PAIN 54 0.0002
679 ANURIA 2 0.0002
680 RESPIRATORY TRACT INFECTION 6 0.0002
681 CHILLS 27 0.0002
682 SEPTIC SHOCK 10 0.0002
683 MUSCULOSKELETAL PAIN 12 0.0002
684 APPLICATION SITE ERYTHEMA 6 0.0002
685 DYSGEUSIA 17 0.0002
686 EOSINOPHILIA 4 0.0002
687 BURNING SENSATION 16 0.0002
688 INFECTION 33 0.0002
689 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
690 SARS-COV-2 TEST POSITIVE 3 0.0002
691 SLEEP DISORDER 16 0.0002
692 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
693 WEIGHT DECREASED 63 0.0002
694 GLOSSODYNIA 5 0.0002
695 HAEMARTHROSIS 2 0.0002
696 ADVERSE DRUG REACTION 20 0.0002
697 OVERDOSE 48 0.0002
698 BONE PAIN 13 0.0002
699 THROAT TIGHTNESS 6 0.0002
700 DRUG TOXICITY 3 0.0002
701 EXOSTOSIS 2 0.0002
702 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
703 HAEMATOCHEZIA 12 0.0002
704 INCREASED TENDENCY TO BRUISE 2 0.0002
705 FLUID RETENTION 11 0.0002
706 ORAL DISCOMFORT 3 0.0002
707 POLLAKIURIA 9 0.0002
708 VERTIGO 13 0.0002
709 FEELING ABNORMAL 51 0.0002
710 ARTERIOSCLEROSIS 2 0.0002
711 GASTRIC ULCER 4 0.0002
712 ARTHRALGIA 87 0.0002
713 HERPES ZOSTER 12 0.0002
714 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
715 MYELODYSPLASTIC SYNDROME 3 0.0002
716 ATELECTASIS 2 0.0002
717 TREATMENT FAILURE 17 0.0002
718 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
719 BODY TEMPERATURE DECREASED 2 0.0002
720 LIGAMENT SPRAIN 2 0.0002
721 HYPERHIDROSIS 26 0.0002
722 HAEMATOCRIT DECREASED 4 0.0002
723 IMMUNODEFICIENCY 3 0.0002
724 TREATMENT NONCOMPLIANCE 11 0.0002
725 CHEST PAIN 37 0.0002
726 EPILEPSY 6 0.0002
727 OXYGEN SATURATION DECREASED 11 0.0002
728 EUPHORIC MOOD 2 0.0002
729 OROPHARYNGEAL PAIN 18 0.0002
730 PAIN IN EXTREMITY 57 0.0002
731 CARDIO-RESPIRATORY ARREST 8 0.0002
732 SPEECH DISORDER 10 0.0002
733 ABDOMINAL DISCOMFORT 32 0.0002
734 HEPATIC ENZYME INCREASED 13 0.0002
735 WITHDRAWAL SYNDROME 8 0.0002
736 OFF LABEL USE 166 0.0002
737 PULMONARY EMBOLISM 18 0.0002
738 FULL BLOOD COUNT ABNORMAL 2 0.0002
739 HYPERTENSION 40 0.0002
740 HALLUCINATION, AUDITORY 3 0.0002
741 PRODUCTIVE COUGH 9 0.0002
742 PLATELET COUNT DECREASED 20 0.0002
743 LIVER FUNCTION TEST INCREASED 4 0.0002
744 NIGHT SWEATS 6 0.0002
745 POOR QUALITY SLEEP 4 0.0002
746 HOT FLUSH 14 0.0002
747 INTESTINAL OBSTRUCTION 7 0.0002
748 FREQUENT BOWEL MOVEMENTS 5 0.0002
749 DEEP VEIN THROMBOSIS 12 0.0002
750 AMNESIA 12 0.0002
751 CONDITION AGGRAVATED 56 0.0002
752 OESOPHAGITIS 2 0.0002
753 METASTASES TO BONE 3 0.0002
754 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
755 ABDOMINAL DISTENSION 19 0.0002
756 GASTROINTESTINAL PAIN 2 0.0002
757 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
758 ASTHENIA 68 0.0002
759 DIVERTICULITIS 5 0.0002
760 VIRAL INFECTION 6 0.0002
761 TRANSAMINASES INCREASED 4 0.0002
762 BLOOD UREA INCREASED 3 0.0002
763 DEMENTIA 5 0.0002
764 THROAT IRRITATION 8 0.0002
765 FACE OEDEMA 3 0.0002
766 HEART RATE IRREGULAR 4 0.0002
767 EXPOSURE DURING PREGNANCY 11 0.0002
768 PRODUCT AVAILABILITY ISSUE 4 0.0002
769 MICTURITION URGENCY 2 0.0002
770 FATIGUE 136 0.0002
771 INFLAMMATION 9 0.0002
772 GASTRIC HAEMORRHAGE 2 0.0002
773 MUSCULOSKELETAL STIFFNESS 15 0.0002
774 THROMBOCYTOPENIA 19 0.0002
775 COVID-19 PNEUMONIA 2 0.0002
776 INSOMNIA 45 0.0002
777 TACHYCARDIA 15 0.0002
778 OESOPHAGEAL CARCINOMA 5 0.0002
779 BACTERAEMIA 2 0.0002
780 ISCHAEMIC STROKE 3 0.0002
781 RHABDOMYOLYSIS 7 0.0002
782 HEADACHE 105 0.0002
783 SKIN EXFOLIATION 14 0.0002
784 BLOOD PRESSURE DECREASED 11 0.0002
785 COVID-19 29 0.0002
786 URINARY TRACT INFECTION 28 0.0002
787 LOSS OF CONSCIOUSNESS 21 0.0002
788 CEREBRAL INFARCTION 4 0.0002
789 MUSCLE SPASTICITY 2 0.0002
790 CARDIOMEGALY 2 0.0002
791 ABNORMAL WEIGHT GAIN 2 0.0002
792 INFLUENZA 18 0.0002
793 VISUAL IMPAIRMENT 20 0.0002
794 HEPATIC STEATOSIS 3 0.0002
795 DRY EYE 8 0.0002
796 MEMORY IMPAIRMENT 22 0.0002
797 ABDOMINAL PAIN LOWER 4 0.0002
798 LIVER DISORDER 7 0.0002
799 SLEEP APNOEA SYNDROME 3 0.0002
800 INJECTION SITE IRRITATION 2 0.0002
801 COUGH 44 0.0002
802 MYDRIASIS 2 0.0002
803 HIP FRACTURE 5 0.0002
804 ILLNESS 16 0.0002
805 PRESCRIBED OVERDOSE 3 0.0002
806 EAR PAIN 3 0.0002
807 NEPHROLITHIASIS 7 0.0002
808 CHOLELITHIASIS 5 0.0002
809 OSTEONECROSIS 5 0.0002
810 IMMUNE SYSTEM DISORDER 2 0.0002
811 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
812 RESPIRATORY FAILURE 11 0.0002
813 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
814 ABORTION SPONTANEOUS 6 0.0001
815 SPINAL FRACTURE 3 0.0001
816 IRRITABILITY 9 0.0001
817 MALIGNANT MELANOMA 2 0.0001
818 INTENTIONAL SELF-INJURY 3 0.0001
819 PRODUCT ADMINISTRATION ERROR 3 0.0001
820 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
821 INJURY ASSOCIATED WITH DEVICE 3 0.0001
822 GAIT DISTURBANCE 28 0.0001
823 DIABETES MELLITUS 11 0.0001
824 COORDINATION ABNORMAL 2 0.0001
825 MASS 2 0.0001
826 BLOOD TEST ABNORMAL 2 0.0001
827 BLINDNESS UNILATERAL 2 0.0001
828 RETCHING 3 0.0001
829 HYPERSOMNIA 4 0.0001
830 HYPERTHYROIDISM 2 0.0001
831 INJECTION SITE HAEMATOMA 2 0.0001
832 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
833 DYSPHAGIA 13 0.0001
834 LABORATORY TEST ABNORMAL 4 0.0001
835 STEVENS-JOHNSON SYNDROME 3 0.0001
836 ECZEMA 7 0.0001
837 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
838 PRODUCT USE ISSUE 25 0.0001
839 APPLICATION SITE PRURITUS 3 0.0001
840 ILL-DEFINED DISORDER 8 0.0001
841 CHRONIC KIDNEY DISEASE 10 0.0001
842 FEELING HOT 8 0.0001
843 PERICARDIAL EFFUSION 3 0.0001
844 GYNAECOMASTIA 4 0.0001
845 ANKLE FRACTURE 2 0.0001
846 SWELLING 12 0.0001
847 NERVOUS SYSTEM DISORDER 4 0.0001
848 PLASMA CELL MYELOMA 5 0.0001
849 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
850 CYANOSIS 2 0.0001
851 DISEASE PROGRESSION 15 0.0001
852 ANXIETY 36 0.0001
853 OCULAR HYPERAEMIA 6 0.0001
854 HEAD INJURY 4 0.0001
855 PAIN 76 0.0001
856 FLATULENCE 7 0.0001
857 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
858 IMPAIRED HEALING 4 0.0001
859 STAPHYLOCOCCAL INFECTION 4 0.0001
860 HEART RATE INCREASED 12 0.0001
861 INFUSION RELATED REACTION 8 0.0001
862 FUNGAL INFECTION 4 0.0001
863 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
864 GAIT INABILITY 4 0.0001
865 DYSPHONIA 7 0.0001
866 CANDIDA INFECTION 2 0.0001
867 CARDIOVASCULAR DISORDER 3 0.0001
868 CATARACT 7 0.0001
869 ERECTILE DYSFUNCTION 3 0.0001
870 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
871 DEVICE LEAKAGE 5 0.0001
872 MENTAL DISORDER 5 0.0001
873 HAEMORRHAGE 12 0.0001
874 DRUG WITHDRAWAL SYNDROME 10 0.0001
875 HEAD DISCOMFORT 2 0.0001
876 RENAL FAILURE 15 0.0001
877 GALLBLADDER DISORDER 2 0.0001
878 WEIGHT INCREASED 25 0.0001
879 THERAPY NON-RESPONDER 5 0.0001
880 LEUKOCYTOSIS 2 0.0001
881 LIMB INJURY 3 0.0001
882 SUICIDAL IDEATION 10 0.0001
883 RESPIRATORY DISTRESS 3 0.0001
884 MIDDLE INSOMNIA 2 0.0001
885 CEREBROVASCULAR ACCIDENT 18 0.0001
886 FEBRILE NEUTROPENIA 7 0.0001
887 ACNE 8 0.0001
888 RED BLOOD CELL COUNT DECREASED 3 0.0001
889 PRODUCT SUBSTITUTION ISSUE 6 0.0001
890 DRUG PRESCRIBING ERROR 2 0.0001
891 CHOKING 2 0.0001
892 ORAL HERPES 2 0.0001
893 NASAL CONGESTION 6 0.0001
894 BLOOD PRESSURE ABNORMAL 2 0.0001
895 RESPIRATORY DISORDER 3 0.0001
896 HEPATIC FAILURE 3 0.0001
897 LACRIMATION INCREASED 3 0.0001
898 SUICIDE ATTEMPT 6 0.0001
899 STOMATITIS 6 0.0001
900 BLOOD PRESSURE INCREASED 15 0.0001
901 ADVERSE EVENT 9 0.0001
902 NASOPHARYNGITIS 18 0.0001
903 BRONCHITIS 7 0.0001
904 CYSTITIS 3 0.0001
905 MOOD SWINGS 3 0.0001
906 EATING DISORDER 2 0.0001
907 JOINT INJURY 2 0.0001
908 HYPOACUSIS 4 0.0001
909 DISTURBANCE IN ATTENTION 5 0.0001
910 VAGINAL HAEMORRHAGE 4 0.0001
911 DYSPEPSIA 9 0.0001
912 APPLICATION SITE PAIN 2 0.0001
913 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
914 EXPIRED PRODUCT ADMINISTERED 3 0.0001
915 URINARY RETENTION 3 0.0001
916 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
917 INCORRECT DOSE ADMINISTERED 20 0.0001
918 DRUG INEFFECTIVE 113 0.0001
919 HEART RATE DECREASED 3 0.0001
920 BLADDER CANCER 5 0.0001
921 HOSPITALISATION 13 0.0001
922 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
923 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
924 ACCIDENTAL OVERDOSE 3 0.0001
925 LUNG DISORDER 4 0.0001
926 EXTRAPYRAMIDAL DISORDER 2 0.0001
927 ASTHMA 9 0.0001
928 BLOOD GLUCOSE INCREASED 15 0.0001
929 RHINORRHOEA 5 0.0001
930 HAEMATOMA 2 0.0001
931 NERVOUSNESS 4 0.0001
932 BREAST CANCER FEMALE 2 0.0001
933 PRODUCT DOSE OMISSION ISSUE 22 0.0001
934 MYOCARDIAL INFARCTION 13 0.0001
935 FEAR 2 0.0001
936 EMOTIONAL DISTRESS 9 0.0001
937 LUNG NEOPLASM MALIGNANT 3 0.0001
938 INFLUENZA LIKE ILLNESS 6 0.0001
939 ABNORMAL DREAMS 2 0.0001
940 COMPLETED SUICIDE 6 0.0001
941 ARTHROPATHY 4 0.0001
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
943 THERAPY INTERRUPTED 5 0.0001
944 SKIN BURNING SENSATION 5 0.0001
945 DEVICE DISLOCATION 3 0.0001
946 DYSSTASIA 2 0.0001
947 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
948 COLITIS ULCERATIVE 3 0.0001
949 DEVICE ISSUE 6 0.0001
950 BLOOD POTASSIUM DECREASED 2 0.0001
951 CORONARY ARTERY DISEASE 2 0.0001
952 DRUG ADMINISTRATION ERROR 2 0.0001
953 EMOTIONAL DISORDER 2 0.0001
954 RENAL DISORDER 3 0.0001
955 ARTHRITIS 5 0.0001
956 THROMBOSIS 5 0.0001
957 DEATH 53 0.0001
958 LYMPHADENOPATHY 2 0.0001
959 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
960 HEPATIC FUNCTION ABNORMAL 2 0.0001
961 CARDIAC DISORDER 5 0.0001
962 UNEVALUABLE EVENT 4 0.0001
963 RHEUMATOID ARTHRITIS 6 0.0001
964 DRY SKIN 7 0.0001
965 MIGRAINE 5 0.0001
966 SURGERY 3 0.0001
967 CARDIAC FAILURE CONGESTIVE 4 0.0000
968 EXTRA DOSE ADMINISTERED 2 0.0000
969 DISCOMFORT 3 0.0000
970 SINUSITIS 5 0.0000
971 DEPRESSION 11 0.0000
972 PRODUCT DOSE OMISSION 3 0.0000
973 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
974 DRUG DEPENDENCE 7 0.0000
975 MULTIPLE SCLEROSIS 2 0.0000
976 BLOOD GLUCOSE DECREASED 2 0.0000
977 PSORIASIS 5 0.0000
978 INJECTION SITE HAEMORRHAGE 3 0.0000
979 EYE IRRITATION 2 0.0000
980 PRODUCT STORAGE ERROR 3 0.0000
981 INJECTION SITE ERYTHEMA 4 0.0000
982 ALOPECIA 6 0.0000
983 INJECTION SITE SWELLING 2 0.0000
984 INJECTION SITE PAIN 8 0.0000
985 INJECTION SITE BRUISING 2 0.0000
986 DRUG DOSE OMISSION 3 0.0000
987 NO ADVERSE EVENT 3 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000